News/ News/ R&D Boost for Verona Pharma after trial win with inhaled COPD drug Richard Staines COPD, ensifenitrine, R&D, respiratory 0 Comment UK-based Verona Pharma has scored a new win with its chronic obstructive pulmonary disease (COPD) drug ensifenitrine, after Share X Boost for Verona Pharma after trial win with inhaled COPD drug https://pharmaphorum.com/news/verona-pharma-scores-trial-win-with-inhaled-copd-drug/
